COVID-19: Companion Diagnostics Market Growth in Healthcare at a CAGR of 12.9%
Advantages of companion diagnostics, the growing need for targeted therapy, the rising importance of personalized medicine, the increasing global incidence of cancer, and the ever-increasing application areas of companion diagnostics are driving the growth of the global companion diagnostics industry. The increasing demand for next-generation sequencing, the growing significance of companion diagnostics...
Which technology has a higher adoption rate of companion diagnostics?
According to the new market research report “Companion Diagnostics Market by Product & Service (Assay, Kit, Software & Service), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Lung & Colorectal Cancer, Cardiovascular Disease), End-User (Pharma Companies, CRO), Region — Global Forecast to 2024”, published by MarketsandMarkets™, analyzes and studies the major market drivers,...
Companion Diagnostics Market: Pharmaceutical and Biopharmaceutical Industries Shows Promising Future
The growth of the companion diagnostics market is tied primarily to the advantages of companion diagnostics, the growing need for targeted therapy, the increasing importance of personalized medicine, the rising global incidence of cancer, and the ever-increasing application areas of companion diagnostics.
What the Market Looks Like?
Predicted to grow at a CAGR of 15.7% during the...
Global Companion Diagnostics Market Top Players, Business Opportunities, Latest Industry Trends And Applications
A companion diagnostic assay is an in vitro diagnostic device (IVD) that is used to identify whether a patient with certain diseases could be benefitted by a particular drug through the biomarker assessment.
The key factors driving the growth of this market include the increasing lung cancer cases, growing number of genetic testing, rising need for personalized medicines, and regulatory guidelines...
Overview of Companion Diagnostics in the Pharmaceutical and Biopharmaceutical Industry
A companion diagnostic assay is an in vitro diagnostic device (IVD) that is used to identify whether a patient with certain diseases could be benefitted by a particular drug through the biomarker assessment. The key factors driving the growth of this market include the increasing lung cancer cases, growing number of genetic testing, rising need for personalized medicines, and regulatory guidelines...
Companion Diagnostics Market, By End User
According to the new market research “Companion Diagnostics Market by Technology (PCR, IHC, NGS, ISH), Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) – Global Forecast to 2022″, The global companion diagnostic market is expected to reach USD 6.51...
Companion Diagnostics Market, By Technology
According to the new market research “Companion Diagnostics Market by Technology (PCR, IHC, NGS, ISH), Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) – Global Forecast to 2022″, The global companion diagnostic market is expected to reach USD 6.51...
Global Companion Diagnostics Market, By Technology, 2015–2022 (USD Million)
According to the new market research “Companion Diagnostics Market by Technology (PCR, IHC, NGS, ISH), Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) – Global Forecast to 2022″, The global companion diagnostic market is expected to reach USD 6.51 Billion...
Companion Diagnostics Market expected to reach worth $6.51 Billion till 2022
The report “Companion Diagnostics Market by Technology (PCR, IHC, NGS, ISH), Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) – Global Forecast to 2022″, The global companion diagnostic market is expected to reach USD 6.51 Billion by 2022 from USD...
Companion Diagnostics Market worth $6.51 Billion by 2022
The report “Companion Diagnostics Market by Technology (PCR, IHC, NGS, ISH), Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) – Global Forecast to 2022″, The global companion diagnostic market is expected to reach USD 6.51 Billion by 2022 from USD...